What question did this study set out to answer?

This study evaluates the safety and effectiveness of sublingual nitroglycerin in managing retained placenta compared to placebo.

May 8, 2026Medical Journal of BabylonOpen Access

Sublingual Nitroglycerin in Managing Retained Placenta: A Placebo-controlled Trial

View Full Paper

Ask AI

Bookmark

This study evaluates the safety and effectiveness of sublingual nitroglycerin in managing retained placenta compared to placebo.
Single-blind randomized controlled trial involving 50 females with retained placenta.
Participants received either sublingual nitroglycerin (1 mg) or a placebo, with assessment of successful placental delivery as the main outcome.
Secondary outcomes included blood pressure, heart rate, blood loss, and side effects.
NTG-treated group achieved 72% effective placental detachment compared to 20% in the placebo group (P = 0.001).
No significant differences in blood loss or placental detachment time between groups.
Headaches occurred more frequently in the NTG group (56%) compared to the placebo group (8%) (P = 0.0002).

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Randomized trial evaluates sublingual nitroglycerin against placebo for retained placenta management, suggesting higher effectiveness but increased side effects.

Cite This Study

Jasim et al. (2026) studied this question.

synapsesocial.com/papers/69fd7f25bfa21ec5bbf078ac https://doi.org/10.4103/mjbl.mjbl_889_24

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial evaluates sublingual nitroglycerin against placebo for retained placenta management, suggesting higher effectiveness but increased side effects.

Sublingual Nitroglycerin in Managing Retained Placenta: A Placebo-controlled Trial

Key Points

Discussion

Implication

Cite This Study

Sublingual Nitroglycerin in Managing Retained Placenta: A Placebo-controlled Trial

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider